Literature DB >> 31548223

Predictive Genetic Counseling for Neurodegenerative Diseases: Past, Present, and Future.

Jill S Goldman1.   

Abstract

Predictive genetic counseling for neurodegenerative diseases commenced with Huntington's disease (HD). Because the psychological issues and outcomes have been best studied in HD, the HD genetic counseling and testing protocol is still accepted as the gold standard for genetic counseling for these diseases. Yet, advances in genomic technology have produced an abundance of new information about the genetics of diseases such as Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, and Parkinson's disease. The resulting expansion of genetic tests together with the availability of direct-to-consumer testing and clinical trials for treatment of these diseases present new ethical and practical issues requiring modifications to the protocol for HD counseling and new demands on both physicians and genetic counselors. This work reviews the history of genetic counseling for neurodegenerative diseases, its current practice, and the future direction of genetic counseling for these conditions.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31548223      PMCID: PMC7328452          DOI: 10.1101/cshperspect.a036525

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  90 in total

1.  Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study.

Authors:  Maria U Larsson; Mary A Luszcz; The-Hung Bui; Tarja-Brita Robins Wahlin
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

Review 2.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.

Authors:  S G Post; P J Whitehouse; R H Binstock; T D Bird; S K Eckert; L A Farrer; L M Fleck; A D Gaines; E T Juengst; H Karlinsky; S Miles; T H Murray; K A Quaid; N R Relkin; A D Roses; P H St George-Hyslop; G A Sachs; B Steinbock; E F Truschke; A B Zinn
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

3.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

4.  Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.

Authors:  Maria Pia Giannoccaro; Anna Bartoletti-Stella; Silvia Piras; Annalisa Pession; Patrizia De Massis; Federico Oppi; Michelangelo Stanzani-Maserati; Elena Pasini; Simone Baiardi; Patrizia Avoni; Piero Parchi; Rocco Liguori; Sabina Capellari
Journal:  J Neurol       Date:  2017-06-15       Impact factor: 4.849

5.  Genetic screening raises questions for employers and insurers.

Authors:  G Kolata
Journal:  Science       Date:  1986-04-18       Impact factor: 47.728

Review 6.  Presymptomatic ALS genetic counseling and testing: Experience and recommendations.

Authors:  Michael Benatar; Christine Stanislaw; Eliana Reyes; Sumaira Hussain; Anne Cooley; Maria Catalina Fernandez; Danielle D Dauphin; Sara-Claude Michon; Peter M Andersen; Joanne Wuu
Journal:  Neurology       Date:  2016-05-18       Impact factor: 9.910

7.  Impact on couple relationships of predictive testing for Huntington disease: a longitudinal study.

Authors:  Fiona Richards; Katrina Williams
Journal:  Am J Med Genet A       Date:  2004-04-15       Impact factor: 2.802

8.  Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.

Authors:  Michael R Cassidy; J Scott Roberts; Thomas D Bird; Ellen J Steinbart; L Adrienne Cupples; Clara A Chen; Erin Linnenbringer; Robert C Green
Journal:  Alzheimers Dement       Date:  2008-11       Impact factor: 21.566

9.  Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.

Authors:  J Scott Roberts; Susan A LaRusse; Heather Katzen; Peter J Whitehouse; Melissa Barber; Stephen G Post; Norman Relkin; Kimberly Quaid; Robert H Pietrzak; L Adrienne Cupples; Lindsay A Farrer; Tamsen Brown; Robert C Green
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

10.  Attitudes of persons at risk for Huntington disease toward predictive testing.

Authors:  S Kessler; T Field; L Worth; H Mosbarger
Journal:  Am J Med Genet       Date:  1987-02
View more
  7 in total

1.  Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study.

Authors:  Jackie M Poos; Esther van den Berg; Janne M Papma; Fleur C van der Tholen; Harro Seelaar; Laura Donker Kaat; J Anneke Kievit; Aad Tibben; John C van Swieten; Lize C Jiskoot
Journal:  Front Psychiatry       Date:  2022-04-27       Impact factor: 5.435

Review 2.  Genetic Counseling and the Central Tenets of Practice.

Authors:  Barbara Biesecker
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

3.  Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Vasiliki Efthymiou; George P Chrousos
Journal:  BMC Med       Date:  2021-01-13       Impact factor: 8.775

Review 4.  Mapping the Diverse and Inclusive Future of Parkinson's Disease Genetics and Its Widespread Impact.

Authors:  Inas Elsayed; Alejandro Martinez-Carrasco; Mario Cornejo-Olivas; Sara Bandres-Ciga
Journal:  Genes (Basel)       Date:  2021-10-23       Impact factor: 4.096

5.  Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol.

Authors:  Anna Mega; Samantha Galluzzi; Cristian Bonvicini; Silvia Fostinelli; Massimo Gennarelli; Cristina Geroldi; Orazio Zanetti; Luisa Benussi; Emilio Di Maria; Giovanni B Frisoni
Journal:  Alzheimers Res Ther       Date:  2020-11-17       Impact factor: 6.982

Review 6.  Genetic Counselling Improves the Molecular Characterisation of Dementing Disorders.

Authors:  Stefania Zampatti; Michele Ragazzo; Cristina Peconi; Serena Luciano; Stefano Gambardella; Valerio Caputo; Claudia Strafella; Raffaella Cascella; Carlo Caltagirone; Emiliano Giardina
Journal:  J Pers Med       Date:  2021-05-26

7.  Knowledge assessment and psychological impact of genetic counseling in people at risk for familial FTD.

Authors:  Bonnie Wong; Diane Lucente; Samantha Krivensky; Erin Krahn; Jason Karlawish; Bradford C Dickerson
Journal:  Alzheimers Dement (Amst)       Date:  2021-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.